Biomedical scientists review recent research into diseases caused by protozoans and how to prevent them, emphasizing the role that genomics is now playing in the effort. Among their topics are high-throughput screenings: new breeze in anti-Trypanosoma cruzi drug discovery, protein glycosylation in Trypanosoma cruzi and strategies based on mass spectrometry for characterizing glycans and glycoproteins, omics approaches for understanding gene expression in Leishmania: clues for tackling Leishmaniasis, Entamoeba histolytica: from high-throughput technology to new drugs, and gene silencing and therapeutic targets against Acanthamoeba infections. Distributed in the US by Ingram Content Group. Annotation ©2018 Ringgold, Inc., Portland, OR (protoview.com)
